More about

Head And Neck Cancer

News
April 07, 2021
1 min read
Save

FDA approves new Erbitux dosing regimen for colorectal, head and neck cancers

FDA approves new Erbitux dosing regimen for colorectal, head and neck cancers

The FDA approved a new cetuximab dosage regimen for the treatment of patients with KRAS wild-type, EGFR-expressing colorectal cancer or squamous cell carcinoma of the head and neck, according to a press release.

News
April 03, 2021
1 min read
Save

Eight important updates for Head and Neck Cancer Awareness Month

Eight important updates for Head and Neck Cancer Awareness Month

April is Head and Neck Cancer Awareness Month.

News
April 01, 2021
1 min read
Save

FDA clears IND application for immunotherapy combination to treat solid tumors

FDA clears IND application for immunotherapy combination to treat solid tumors

The FDA cleared an investigational new drug application for the combination of AFM24 and SNK-01 in patients with solid tumors that express epidermal growth factor receptor, according to a joint press release from each agent’s manufacturer.

News
March 24, 2021
5 min read
Save

Financial toxicity associated with poorer head and neck cancer survival outcomes

Financial toxicity associated with poorer head and neck cancer survival outcomes

Patients with head and neck cancer who reported high financial toxicity at baseline appeared nearly twice as likely to experience poor outcomes, according to study results published in Oral Oncology.

News
March 01, 2021
3 min read
Save

Exposure to artificial light at night may increase risk for thyroid cancer

Exposure to artificial light at night may increase risk for thyroid cancer

Living in an area with higher levels of outdoor artificial nighttime light appeared associated with higher risk for developing thyroid cancer, according to an observational study published in Cancer.

News
February 25, 2021
1 min read
Save

FDA grants breakthrough therapy designation to Cabometyx for thyroid cancer subset

FDA grants breakthrough therapy designation to Cabometyx for thyroid cancer subset

The FDA granted breakthrough therapy designation to cabozantinib for treatment of certain patients with thyroid cancer, according to the agent’s manufacturer.

News
February 22, 2021
3 min read
Save

GERD may increase risk for cancers of the larynx, esophagus

GERD may increase risk for cancers of the larynx, esophagus

GERD appeared to increase risk for esophageal adenocarcinoma, esophageal squamous cell carcinoma and laryngeal squamous cell carcinoma, according to results of a study published in Cancer.

News
January 31, 2021
1 min read
Save

Roswell Park promotes four physicians to leadership roles

Roswell Park promotes four physicians to leadership roles

Roswell Park Comprehensive Cancer Center has promoted four physicians to leadership roles in its clinical research program.

News
January 16, 2021
1 min read
Save

Rutgers Cancer Institute of New Jersey appoints immunotherapy chief

Rutgers Cancer Institute of New Jersey appoints immunotherapy chief

Christian Hinrichs, MD, has been appointed chief of the section of cancer immunotherapy at Rutgers Cancer Institute of New Jersey.

News
December 01, 2020
1 min read
Save

FDA approves Gavreto for RET-altered thyroid cancers

FDA approves Gavreto for <i>RET</i>-altered thyroid cancers

The FDA granted accelerated approval to pralsetinib for treatment of certain patients with RET-altered thyroid cancer.

View more